Get the Weekly Intelligence Brief — top committee picks every Sunday.

ICLR vs MANE

ICON Public Limited Company vs Veradermics, Incorporated — AI-powered side-by-side comparison
ICLR
ICON Public Limited Company
68
Buy
VS
MANE
Veradermics, Incorporated
71
Buy
MetricICLRMANE
AI Score 68 71
Price $163.01 $112.65
P/E Ratio 39.04× -51.87×
ROE 2.5% 57.8%
Revenue Growth YoY
Gross Margin 21.8% 0.0%
Debt / Equity 0.37× 0.00×
Dividend Yield 0.0% 0.0%
RSI (14) 55.0 53.1
Beta 1.203 1.3492
Expected Upside +17.5% +4.8%

AI Committee View

Current Innellis committee reasoning for ICLR versus MANE.
MANE leads by 3 points.

MANE scores 71/100 (Buy) versus ICLR at 68/100 (Buy).

ICLR Committee View
50% agreement
4 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
MANE Committee View
80% agreement
5 analysts

The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. Most analysts agree, and no major concerns are blocking a stronger rating.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • Risk/reward is unfavorable: 21.2% downside vs 4.8% upside.
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ICLR Full Analysis MANE Full Analysis